•  
  •  
  •  
  •  

2026-08-11 09:53:33

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Lemon Tree Hotels signs Second hotel in Mcleodganj
  • Axis Mutual Fund launches Axis Nifty Energy Index Fund & Axis Nifty Energy ETF NFOs offering exposure to India's evolving capital energy ecosystem
  • Websol Energy Q1FY27 Revenue up 70% YoY at Rs 373 crore; Company Prepays Entire IREDA Term Loan
  • CPPIB to Invest ₹3,000 Crore in Prestige Estates' Hospitality Arm PHVL for Up to 28% Stake
  • Krystal Integrated Services Consortium Secures ₹740 Crore Urban Wastewater Contracts in Maharashtra

Keywords Selected:  Brazil

Stock Report

  • Concord Biotech Ltd completes ANVISA Inspection conducted by the Brazilian Health Regulatory Agency at the Limbasi API Manufacturing Facility
  • Tyche Industries Ltd receives ANIVSA, Brazil GMP Certificate for Kakinada facility
  • Wanbury Ltd - Sertraline Form II approval received from ANVISA, BRAZIL
  • APSEZ, NMDC and Vale Brazil Sign MoU on Iron Ore
  • Lupin signs exclusive licensing agreement with Neopharmed for Gastroenterology Brand Plasil® in the Philippines and Brazil
  • Eris Lifesciences Receives ANVISA approval at its Ahmedabad campus
  • Shilpa Pharma Lifesciences Limited, Unit-1, ANVISA Audit from Brazil
  • Advanta Seeds Brazil's Strategic Divestment of Serra Bonita Sementes S.A. Assets and Expansion of Key Customer Partnerships in Brazil
  • OneSource Specialty Pharma Ltd secures Brazilian GMP approval for its flagship facility Unit 2
  • EaseMyTrip expands globally with Strategic Investments in Brazil, the Middle East, and the U.S
  • ANVISA - Brazil completes inspection at Caplin Steriles' facility at Gummidipoondi
  • Shilpa Pharma Lifesciences Ltd, Unit 2, Raichur, Karnataka has cleared the ANVISA-Brazil GMP inspection
  • Bajaj Auto arm in Brazil commences commercial production
  • AIA Engineering Limited updates on anti-dumping duties in Brazil
  • Biocon Ltd signs an exclusive licensing and supply agreement for generic Ozempic commercialization in Brazil with Biomm S.A.
  • TCS announces New Delivery Center in Londrina, Brazil
  • Cupid Ltd executes Commercial Agreement for Supply of Female Condoms in Brazil worth INR 23.07 Crore
  • Pidilite Industries Ltd to divest its stake in Pulvitec, Brazil
  • Supriya Lifesciences Ltd received GMP certification from ANVISA Brazil
  • Gufic Biosciences Ltd receives TGA Australia and ANVISA Brazil approval for Parecoxib 40mg injection
  • Wipro and Amigos do Bem join forces to bring Wipro Cares to Brazil
  • Granules India Limited received approval from Brazilian Health Regulatory Agency ANVISA
  • Royal Enfield commences operations of new CKD assembly facility in Brazil
  • Lupin's Brazilian Subsidiary, MedQuimica Acquires Rights to Nine Brands from Bausch Health

Industry News

  • Sterlite Power wins second lot in transmission auction in Brazil

Latest Post

  • Lemon Tree Hotels signs Second hotel in Mcleodganj
  • Axis Mutual Fund launches Axis Nifty Energy Index Fund & Axis Nifty Energy ETF NFOs offering exposure to India's evolving capital energy ecosystem
  • Websol Energy Q1FY27 Revenue up 70% YoY at Rs 373 crore; Company Prepays Entire IREDA Term Loan
  • CPPIB to Invest ₹3,000 Crore in Prestige Estates' Hospitality Arm PHVL for Up to 28% Stake
  • Krystal Integrated Services Consortium Secures ₹740 Crore Urban Wastewater Contracts in Maharashtra


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025